相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Miguel Hie et al.
BLOOD (2014)
Syndromes of Thrombotic Microangiopathy
James N. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Influence of plasma exchange on rituximab pharmacokinetics
Nicolas Azzopardi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease
Florent Puisset et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases
Myrna Pequeno-Luevano et al.
HEMATOLOGY (2013)
Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse
J-P. Westwood et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's) Ten-year experience at a single center
Rodrigo Cartin-Ceba et al.
ARTHRITIS AND RHEUMATISM (2012)
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini et al.
BLOOD (2012)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Antoine Froissart et al.
CRITICAL CARE MEDICINE (2012)
Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura
Paul Coppo et al.
PRESSE MEDICALE (2012)
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2011)
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
BLOOD (2010)
Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias
David Gomez-Almaguer et al.
BLOOD (2010)
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)
Hendrik B. Feys et al.
BLOOD (2010)
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Eugene P. Rhee et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura
V. McDonald et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
Paul Coppo et al.
PLOS ONE (2010)
A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Rachel B. Jones et al.
ARTHRITIS AND RHEUMATISM (2009)
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Francesco Zaja et al.
HAEMATOLOGICA (2008)
Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy
Paolo Cravedi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Evaluation of a peptide ELISA for the detection of rituximab in serum
H. Blasco et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Pharmacokinetics of rituximab and its clinical use: Thought for the best use?
Guillaume Cartron et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura
P Coppo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases
F Fakhouri et al.
BLOOD (2005)
Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial
CM Ng et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis
KA Keogh et al.
ARTHRITIS AND RHEUMATISM (2005)
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement
P Coppo et al.
MEDICINE (2004)
Epitope mapping of ADAMTS 13 autoantibodies in acquired thrombotic thrombocytopenic purpura
C Klaus et al.
BLOOD (2004)
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura
F Scheiflinger et al.
BLOOD (2003)
分享论文
